Document:

Exhibit 10.2

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT
(this “Agreement”) is dated as of July 29, 2014 and by and between Bing Mei, an individual (“Executive”),
and Skystar Bio-Pharmaceutical Company, a Nevada corporation having its principal office at 4/F Building B, Chuangye Square, No.
48 Keji Road, Gaoxin District, Xian, Shaanxi Province, People’s Republic of China (the “Company”).

 

WHEREAS, the Company
desires to employ Executive as its Chief Financial Officer on the terms and conditions as set forth hereinafter, and Executive
desires to be so employed;

 

NOW, THEREFORE, IN
CONSIDERATION of the foregoing facts, the mutual covenants and agreements contained herein and other good and valuable consideration,
the parties hereby agree as follows:

 

1.           Employment,
Duties and Acceptance.

 

1.1           Effective
as of the date of this Agreement, the Company hereby agrees to employ Executive as its Chief Financial Officer, and Executive hereby
accepts such employment on the terms and conditions contained in this Agreement.  During the term of this Agreement,
Executive shall make himself available to the Company and to any of its subsidiaries or affiliates as directed to pursue the business
of the Company, subject to the supervision and direction of the Board of Directors of the Company.

 

1.2           The
Board may assign Executive such general management and supervisory responsibilities and executive duties for the Company as are
appropriate and commensurate with Executive’s position as Chief Financial Officer of the Company.

 

1.3       Executive
accepts such employment and agrees to devote all of his business time, energies and attention to the performance of his duties
hereunder and as an executive officer of the Company, except that Executive may simultaneously devote his business time for the
operating of Bing Mei, CPA.

 

2.           Compensation
and Benefits.

 

2.1           The
Company shall pay to Executive a salary at an annual base rate of $210,000 for the term hereof, subject to increases of 5% of the
prior year’s base annual salary each year beginning July 29.  During Executive’s employment, salary will
be paid monthly.

 

2.2           The
Company shall issue to Executive an aggregate 8,000 shares of its common stock in four equal quarterly installments, 2,000 shares
of which shall be issuable on each three-month anniversary hereof.        

 

2.3           During
Executive’s employment under this Agreement, the Company shall include Executive as an insured under an officers and
directors insurance policy with coverage not to exceed $1,000,000.

 

2.4           The
Company shall reimburse Executive for all reasonable business expenses incurred by Executive during Executive’s employment
hereunder to the extent in compliance with the Company’s business expense reimbursement policies in effect from time to time
and upon presentation by Executive of such documentation and records as the Company shall from time to time require, provided that
any expense in excess of $500.00 shall require the prior written approval of the Company.

  

3.           Term
and Termination.

 

3.1           The
term of this Agreement commences as of the consummation of the Agreement and shall continue for three (3) years unless sooner terminated
as herein provided.

 

3.2           If
Executive dies during the term of this Agreement, this Agreement shall thereupon terminate, except that the Company shall pay to
the legal representative of Executive’s estate any accrued and unpaid base salary due Executive pursuant to Section 2.1 hereof
based on the days of service prior to the death and all amounts owing to Executive at the time of termination, including for previously
accrued but unpaid expense reimbursements.

 

3.3           The
Company reserves the right to terminate Executive’s employment upon ten (10) days written notice if, for a continuous or
accumulated period of forty-five (45) days during the one year term of this Agreement, Executive is prevented from discharging
his duties under this Agreement due to any physical or mental disability.  With the exception of the covenants included
in Section 4 below, upon such termination, the obligations of Executive and Company under this Agreement shall immediately cease.  In
the event of a termination pursuant to this section, Executive shall be entitled to receive any accrued and unpaid amounts earned
pursuant to Section 2.1 hereof based on the days of service prior to the death and all amounts owing to Executive at the time of
termination, including for previously accrued but unpaid expense reimbursements.

 

    	 

    	 

    

 

3.4           The
Company reserves the right to declare Executive in default of this Agreement if Executive willfully breaches or habitually neglects
the duties which he is required to perform under the terms of this Agreement, or if Executive commits such acts of dishonesty,
fraud, misrepresentation, gross negligence or willful misconduct as would prevent the effective performance of his duties or which
results in material harm to the Company or its business.  The Company may terminate this Agreement for cause by giving
written notice of termination to Executive.  With the exception of the covenants included in Section 4 below, upon the
date of delivery of the written notice of such termination, the obligations of Executive and the Company under this Agreement shall
immediately cease.  Such termination shall be without prejudice to any other remedy to which the Company may be entitled
either at law, in equity, or under this Agreement.  In the event of a termination pursuant to this section, Executive
shall be entitled to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof.  The Company shall
also pay to Executive all amounts owing to Executive at the time of termination, including for previously accrued but unpaid expense
reimbursements. 

 

3.5           Executive’s
employment may be terminated at any time by Executive upon not less than thirty (30) days written notice by Executive to the Board.  With
the exception of the covenants included in section 4 below, upon such termination the obligations of Executive and the Company
under this Agreement shall immediately cease.  In the event of a termination pursuant to this section, Executive shall
be entitled to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof.  The Company shall also
pay to Executive all amounts owing to Executive at the time of termination, including for previously accrued but unpaid expense
reimbursements.

 

3.6           Company
may terminate Executive’s employment upon not less than thirty (30) days written notice by Company to Executive.  With
the exception of the covenants included in section 4 below, upon such termination the obligations of Executive and the Company
under this Agreement shall immediately cease.  In the event of a termination pursuant to this section, Executive shall
be entitled to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof based on the days of service prior
to the termination and all amounts owing to Executive at the time of termination, including for previously accrued but unpaid expense
reimbursements.

 

3.7           In
the event of termination of Executive’s employment prior to the expiration of this Agreement, shares of the Company’s
common stock owed to Executive pursuant to Section 2.2 that are unvested as of the termination date shall expire on the termination
date.

 

4.           Protection
of Confidential Information; Non-Competition, Corporate Opportunities.

 

4.1          Executive
acknowledges that:

 

(a)           As
a result of his employment with the Company, Executive will obtain secret and confidential information concerning the business
of the Company and its subsidiaries and affiliates (referred to collectively in this Article 4 as the “Group”),
including, without limitation, trade secrets and any information concerning products, processes, formulas, designs, inventions
(whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to practice), discoveries,
concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data, know-how, software,
formats, marketing plans, and analyses, business plans and analyses, strategies, forecasts, customer and supplier identities, characteristics
and agreement (“Confidential Information”).  In addition, Executive may become aware of business
opportunities that may be beneficial to the Group including, but not limited, opportunities to acquire or purchase, or, except
for Permitted Competitive Investments, otherwise make equity or debt investments in, companies primarily involved in a Competitive
Business (“Corporate Opportunities”), while Executive is an employee of Company, whether in the course
of his employment or otherwise, and that such Corporate Opportunities shall considered to be business opportunities of the Group.

 

(b)          The
Group will suffer substantial damage which will be difficult to compute if, during the period of his employment with the Group
or thereafter, Executive should enter a business competitive with the Group or divulge Confidential Information.

 

(c)          The
provisions of this Agreement are reasonable and necessary for the protection of the business of the Group.

 

4.2          Executive
agrees that he will not at any time, either during the term of this Agreement or thereafter, divulge to any person or entity any
Confidential Information obtained or learned by him as a result of his employment with the Group, except (i) in the course
of performing his duties hereunder, (ii) to the extent that any such information is in the public domain other than as a result
of Executive’s breach of any of his obligations hereunder, (iii) where required to be disclosed by court order, subpoena
or other government process, or (iv) if such disclosure is made without Executive’s knowing intent to cause material
harm to the Group.  If Executive shall be required to make disclosure pursuant to the provisions of clause (iii) of the
preceding sentence, Executive promptly, but in no event more than 24 hours after learning of such subpoena, court order, or other
government process, shall notify, by personal delivery or by electronic means, confirmed by mail, the Company and, at the Company’s
expense, Executive shall: (a) take reasonably necessary and lawful steps required by the Group to defend against the enforcement
of such subpoena, court order or other government process, and (b) permit the Group to intervene and participate with counsel of
its choice in any proceeding relating to the enforcement thereof.

  

4.3         Upon
termination of his employment with the Company, Executive will promptly deliver to the Group all memoranda, correspondence, notes,
records, reports, manuals, drawings, blue-prints and other documents (and all copies thereof) relating to the business of the Group
and all property associated therewith, which he may then possess or have under his control whether prepared by Executive or others.

 

    	 

    	 

    

 

4.4           During
the term of this Agreement and terminating three years after termination of employment, Executive, without the prior written permission
of the Company, shall not for any reason whatsoever, (i) enter into the employ of or render any services to any person, firm or
corporation engaged in any business which is in competition with the Group’s principal existing business at the time of termination
(“Competitive Business”); (ii) engage in any Competitive Business as an individual, partner, shareholder,
creditor, director, officer, principal, agent, employee, trustee consultant, advisor or in any other relationship or capacity;
(iii) employ, or have or cause any other person or entity to employ, any person who was employed by the Group at the time of termination
of Executive’s employment by the Company; or (iv) solicit, interfere with, or endeavor to entice away from the Group, for
the benefit of a Competitive Business, any of its customers.  Notwithstanding the foregoing, (i) Executive shall not
be precluded from investing and managing the investment of, his or his family’s assets in the securities of any corporation
or other business entity which is engaged in a Competitive Business if such securities are traded on a national stock exchange
or in the over-the-counter market and if such investment does not result in his beneficially owning, at any time, more than 2%
of any class of the publicly-traded equity securities of such Competitive Business (“Permitted Competitive
Investment”); and (ii) during the term of this Agreement and terminating one year after termination of Executive’s
employment (except for investments in a class of securities trading on public markets), Executive: (a) shall be prohibited from
taking for himself personally any Corporate Opportunities, and (b) shall refer to the Company for consideration (before any other
party) any and all Corporate Opportunities that arise during the term of this Agreement or for a period of one year thereafter.  If
the Company determines not to exploit any Corporate Opportunity, the Company shall determine what, if anything, should be done
with such opportunity.  Executive shall not be entitled to any compensation, as a finder or otherwise, if either the
Company or Executive introduces such opportunity to other persons, it being understood that any such compensation shall be paid
to the Company.

 

4.5           If
Executive commits a breach of any of the provisions of Sections 4.2 or 4.4, the Company shall have the right:

 

  (a)           to
have the provisions of this Agreement specifically enforced by any court having equity jurisdiction, it being acknowledged and
agreed by Executive that the services being rendered hereunder to the Company are of a special, unique and extraordinary character
and that any breach or threatened breach will cause irreparable injury to the Group and that money damages will not provide an
adequate remedy to the Group; and

 

 (b)           to
require Executive to account for and pay over to the Company all monetary damages determined by a non-appealable decision by a
court of law to have been suffered by the Group as the result of any actions constituting a breach of any of the provisions of
Section 4.2 or 4.4, and Executive hereby agrees to account for and pay over such damages to the Company.

 

 (c)          to
not perform any obligation owed to Executive under this Agreement, to the fullest extent permitted by law.  Company shall
also have the right, to the fullest extent permitted by law, to adjust any amount due and owing or to be due and owing to Executive,
whether under this Agreement or any other agreement between Company and Executive in order to satisfy any losses to the Group as
a result of Executive’s breach.

 

4.6           If
Executive shall violate any covenant contained in Section 4.4, the duration of such covenant so violated shall be automatically
extended for a period of time equal to the period of such violation.

 

5.           Miscellaneous
Provisions.

 

5.1           All
notices provided for in this Agreement shall be in writing, and shall be deemed to have been duly given when delivered personally
to the party to receive the same, when delivered via overnight courier providing for next day delivery service (“Overnight
Courier”), when transmitted by facsimile (electronic receipt confirmed), or when mailed first class postage prepaid, by certified
mail, return receipt requested, addressed to the party to receive the same at his or its address or fax number set forth on the
signature page hereof, or such other address as the party to receive the same shall have specified by written notice given in the
manner provided for in this Section 5.1.  All notices shall be deemed to have been given: (a) as of the date of personal
delivery, (b) the first business day after delivery via Overnight Courier, (c) on the electronically confirmed date of receipt
during business hours of the facsimile transmittal (or the following business day if the facsimile is received after 5:30 p.m.
PDT), or (d) three calendar days after the date of deposit (postage pre-paid) with the U.S. Postal Service if delivered via first
class or certified mail.

 

5.2           In
the event of any claims, litigation or other proceedings arising under this Agreement, Executive shall be reimbursed by the Company
within sixty (60) days after delivery to the Company of statements for the costs incurred by Executive in connection with the analysis,
defense and prosecution thereof, including reasonable attorneys’ fees and expenses; provided, however, that Executive shall
reimburse the Company for all such costs if it is determined by a non-appealable final decision of a court of law that Executive
shall have acted in bad faith with the intent to cause material damage to the Company in connection with any such claim, litigation
or proceeding.

 

5.3           The
Company, shall to the fullest extent permitted by law, indemnify Executive for any liability, damages, losses, costs and expenses
arising out of alleged or actual claims made against Executive for any actions or omissions as an officer and/or director of the
Company or its subsidiary.  To the extent that the Company obtains directors and officers insurance coverage for any
period in which Executive was an officer, director or consultant to the Company, Executive shall be a named insured and shall be
entitled to coverage thereunder.

 

5.4           The
provisions of Article 4, Sections 5.2 and 5.3, and any provisions relating to payments owed to Executive after termination of employment
shall survive termination of this Agreement for any reason.

 

5.5           This
Agreement sets forth the entire agreement of the parties relating to the employment of Executive and is intended to supersede all
prior negotiations, understandings and agreements.  No provisions of this Agreement may be waived or changed except by
writing by the party against whom such waiver or change is sought to be enforced.  The failure of any party to require
performance of any provision hereof or thereof shall in no manner affect the right at a later time to enforce such provision.

 

5.6           All
questions with respect to the construction of this Agreement, and the rights and obligations of the parties hereunder, shall be
determined in accordance with the law of the State of California applicable to agreements made and to be performed entirely in
the State of California.  Any disputes, claims or causes of action by one party against the other arising out of, in
related to or concerning this Agreement shall be commenced and maintained in any state or federal court located in Los Angeles
County of the State of California, and Executive hereby submits to the jurisdiction and venue of any such court.

 

    	 

    	 

    

  

5.7           This
Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company.  This Agreement
shall not be assignable by Executive, but shall inure to the benefit of and be binding upon Executive’s heirs and legal representatives.

 

5.8           It
is the desire and intent of the parties that the terms, provisions, covenants and remedies contained in this Agreement shall be
enforceable to the fullest extent permitted by law.  If any such term, provision, covenant or remedy of this Agreement
or the application thereof to any person or circumstances shall, to any extent, be construed to be invalid or unenforceable in
whole or in part, then such term, provision, covenant or remedy shall be construed in a manner so as to permit its enforceability
under the applicable law, to the fullest extent permitted by law.  In any case, the remaining provisions of the Agreement
and the application thereof to any person or circumstance other than those to which they have been held invalid or unenforceable,
shall remain valid and in full force and effect.

 

[Remainder of Page Intentionally Blank]

 

    	 

    	 

    

  

IN WITNESS WHEREOF,
the parties have executed this Employment Agreement as of the date first above written.

 

	“COMPANY”	 	“EXECUTIVE”
	 	 	 
	SKYSTAR BIO-PHARMACEUTICAL	 	BING MEI
	COMPANY	 	 
	 	 	 
	WEIBING LU	 	BING MEI
	_____________________________	 	_______________________________
	By: Weibing Lu	 	 
	Its: Chief Executive Officer	 	Address:
	 	 	42800 Ridgeway Drive
	Address:	 	Ashburn, VA 20148
	4/F Building B, Chuangye Square	 	USA
	No. 48 Keji Road, Gaoxin District 	 	 
	Xian, Shaanxi Province, PRC	 	Fax:
	Attn: Weibing Lu	 	 
	 	 	 
	Fax:Exhibit 4.1

 

 

 

SECOND SUPPLEMENTAL INDENTURE

 

Dated as of August 1, 2014

 

 

 

TO THE INDENTURE

 

Dated as of April 29, 2014

 

by

 

 

RCS CAPITAL CORPORATION,

 

as Issuer 

 

and

 

WILMINGTON TRUST, NATIONAL ASSOCIATION,

 

as Trustee

 

 

  

    	 

    	 

    

 

THIS
SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of August 1, 2014, is made
by RCS CAPITAL CORPORATION, a Delaware corporation (the “Issuer”), and
WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee (the “Trustee”).

 

WITNESSETH:

 

WHEREAS, an Indenture
dated as of April 29, 2014, was executed by and among the Issuer and the Trustee, relating to the Issuer’s 5.00% Convertible
Senior Notes due 2021 (the “Notes”) (the “Indenture”);

 

WHEREAS, pursuant to
Section 10.01(h) of the Indenture, the Issuer and the Trustee may enter into a supplemental indenture in order to conform the provisions
of the Indenture to the description of the convertible notes in the Commitment Letter;

 

WHEREAS, Section 14.01
of the Indenture, as amended pursuant to the First Supplemental Indenture, dated as of May 5, 2014, reads as follows: “Each
Holder of a Note shall have the right, at such Holder’s option, to convert all or any portion (if the portion to be converted
is $1,000 principal amount or an integral multiple thereof) of such Note at any time prior to the close of business on the Business
Day immediately preceding the Maturity Date, in each case, at an initial conversion rate of the lower of (x) 47.2144 shares of
Common Stock, or (y) if on or before such date the Issuer successfully completes a Well-Marketed, Underwritten Public Offering
of Common Stock, 115% of the price at which the Common Stock is sold to the public in such offering (subject to adjustment as provided
in this Article 14, the “Conversion Rate”) per $1,000 principal amount of Notes (subject to, and in accordance
with, the settlement provisions of Section 14.02, the “Conversion Obligation”)”;

 

WHEREAS, consistent with
the Commitment Letter, the word “lower” in Section 14.01 of the Indenture should have instead been the word “greater”;

 

WHEREAS, the Issuer’s
Common Stock in the Well-Marketed, Underwritten Public Offering of Common Stock was sold at a price equal to $20.25 and, as a result,
under clause (y) of Section 14.01 of the Indenture, each $1,000 principal amount of Notes would be converted into 42.9415 shares
of Common Stock, which is less than 47.2144 shares of Common Stock determined under clause (x) of Section 14.01;

 

WHEREAS, in accordance
with Section 10.01 of the Indenture, this Second Supplemental Indenture shall amend the Indenture as set forth herein;

 

NOW, THEREFORE, in consideration of the agreements
and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged,
the parties hereto hereby agree to the following provisions:

 

Article
1

 

AMENDMENTS TO THE INDENTURE

 

Section
1.1Amendment to Section 14.01 of the Indenture. Section 14.01 of the
Indenture shall be amended and restated in its entirety as follows: “Each Holder of a Note shall have the right,
at such Holder’s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount

 

    	 

    	 

    

 

or an
integral multiple thereof) of such Note at any time prior to the close of business on the Business Day immediately preceding
the Maturity Date, in each case, at an initial conversion rate of 47.2144 (subject to adjustment as provided in this Article
14, the “Conversion Rate”) per $1,000 principal amount of Notes (subject to, and in accordance with, the
settlement provisions of Section 14.02, the “Conversion Obligation”).”

 

Article
2

 

MISCELLANEOUS

 

Section
2.1Trustee Matters. All of the provisions contained in the Indenture in respect
of the rights, privileges, immunities, powers and duties of the Trustee shall be applicable in respect of this Second Supplemental
Indenture as fully and with like effect as if set forth herein in full. The Trustee is not responsible for the validity or sufficiency
of this Second Supplemental Indenture, or for the recitals contained herein. 

 

Section
2.2Ratification. The Indenture is in all respects ratified and confirmed, and the
Indenture and this Second Supplemental Indenture shall be read, taken and construed as one and the same instrument; provided
that in case of conflict between this Second Supplemental Indenture and the Indenture, this Second Supplemental Indenture shall
control.

 

Section
2.3Counterpart Originals. This Second Supplemental Indenture may be simultaneously
executed in several counterparts, each of which shall be deemed to be an original, and such counterparts shall together constitute
one and the same instrument.

 

Section
2.4Severability. In the event any one or more provisions contained in this Second
Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions
shall not in any way be affected or impaired thereby. 

 

Section
2.5Effect of Headings. The Article and Section headings herein have been inserted
for convenience of reference only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms
or provisions hereof.

 

Section
2.6Defined Terms. Any capitalized term used but not defined herein shall have the
meaning set forth in the Indenture. 

 

Section
2.7Governing Law. THIS SECOND SUPPLEMENTAL INDENTURE AND ANY CLAIM, CONTROVERSY
OR DISPUTE ARISING UNDER OR RELATED TO THIS INDENTURE AND EACH NOTE, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE
LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICTS OF LAWS PROVISIONS THEREOF).

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the undersigned have
caused this Second Supplemental Indenture to be duly executed as of the date first written above.

 

 

RCS CAPITAL CORPORATION

 

 

By:/s/
William M. Kahane                    

Name: William M. Kahane

Title: President

 

WILMINGTON TRUST, NATIONAL ASSOCIATION,

as Trustee

 

 

By:/s/
Jane Schweiger                           

Name: Jane Schweiger

Title: Vice President

 

 

 

 

 

(Second Supplemental Indenture)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]